Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 163

1.

Alterations in cellular expression in EBV infected epithelial cell lines and tumors.

Edwards RH, Dekroon R, Raab-Traub N.

PLoS Pathog. 2019 Oct 4;15(10):e1008071. doi: 10.1371/journal.ppat.1008071. eCollection 2019 Oct.

2.

Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus.

Bigi R, Landis JT, An H, Caro-Vegas C, Raab-Traub N, Dittmer DP.

Proc Natl Acad Sci U S A. 2018 Nov 27;115(48):E11379-E11387. doi: 10.1073/pnas.1810128115. Epub 2018 Nov 14.

3.

Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A.

DeKroon RM, Gunawardena HP, Edwards R, Raab-Traub N.

MBio. 2018 Jun 19;9(3). pii: e00959-18. doi: 10.1128/mBio.00959-18.

4.

Viral effects on the content and function of extracellular vesicles.

Raab-Traub N, Dittmer DP.

Nat Rev Microbiol. 2017 Sep;15(9):559-572. doi: 10.1038/nrmicro.2017.60. Epub 2017 Jun 26. Review.

5.

Nasopharyngeal Carcinoma: An Evolving Role for the Epstein-Barr Virus.

Raab-Traub N.

Curr Top Microbiol Immunol. 2015;390(Pt 1):339-63. doi: 10.1007/978-3-319-22822-8_14. Review.

PMID:
26424653
6.

Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.

Marquitz AR, Mathur A, Edwards RH, Raab-Traub N.

J Virol. 2015 Nov;89(22):11256-68. doi: 10.1128/JVI.01492-15. Epub 2015 Aug 26.

7.

Epstein-Barr virus latent membrane protein 2 induces autophagy to promote abnormal acinus formation.

Fotheringham JA, Raab-Traub N.

J Virol. 2015 Jul;89(13):6940-4. doi: 10.1128/JVI.03371-14. Epub 2015 Apr 15.

8.

Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.

Edwards RH, Marquitz AR, Raab-Traub N.

MBio. 2015 Apr 14;6(2). pii: e00441-15. doi: 10.1128/mBio.00441-15.

9.

LMP1 promotes expression of insulin-like growth factor 1 (IGF1) to selectively activate IGF1 receptor and drive cell proliferation.

Tworkoski K, Raab-Traub N.

J Virol. 2015 Mar;89(5):2590-602. doi: 10.1128/JVI.02921-14. Epub 2014 Dec 17.

10.

Expression profile of microRNAs in Epstein-Barr virus-infected AGS gastric carcinoma cells.

Marquitz AR, Mathur A, Chugh PE, Dittmer DP, Raab-Traub N.

J Virol. 2014 Jan;88(2):1389-93. doi: 10.1128/JVI.02662-13. Epub 2013 Nov 13.

11.

Epstein-Barr virus latent membrane protein 2 effects on epithelial acinus development reveal distinct requirements for the PY and YEEA motifs.

Fotheringham JA, Raab-Traub N.

J Virol. 2013 Dec;87(24):13803-15. doi: 10.1128/JVI.02203-13. Epub 2013 Oct 9.

12.

Modulation of B-cell exosome proteins by gamma herpesvirus infection.

Meckes DG Jr, Gunawardena HP, Dekroon RM, Heaton PR, Edwards RH, Ozgur S, Griffith JD, Damania B, Raab-Traub N.

Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):E2925-33. doi: 10.1073/pnas.1303906110. Epub 2013 Jul 1.

13.

The need and challenges for development of an Epstein-Barr virus vaccine.

Cohen JI, Mocarski ES, Raab-Traub N, Corey L, Nabel GJ.

Vaccine. 2013 Apr 18;31 Suppl 2:B194-6. doi: 10.1016/j.vaccine.2012.09.041. Review.

14.

Tousled-like kinases modulate reactivation of gammaherpesviruses from latency.

Dillon PJ, Gregory SM, Tamburro K, Sanders MK, Johnson GL, Raab-Traub N, Dittmer DP, Damania B.

Cell Host Microbe. 2013 Feb 13;13(2):204-14. doi: 10.1016/j.chom.2012.12.005.

15.

Epstein-Barr virus LMP1 modulates lipid raft microdomains and the vimentin cytoskeleton for signal transduction and transformation.

Meckes DG Jr, Menaker NF, Raab-Traub N.

J Virol. 2013 Feb;87(3):1301-11. doi: 10.1128/JVI.02519-12. Epub 2012 Nov 14.

16.

Transcriptome changes induced by Epstein-Barr virus LMP1 and LMP2A in transgenic lymphocytes and lymphoma.

Shair KH, Raab-Traub N.

MBio. 2012 Sep 18;3(5). pii: e00288-12. doi: 10.1128/mBio.00288-12. Print 2012.

17.

Novel mechanisms of EBV-induced oncogenesis.

Raab-Traub N.

Curr Opin Virol. 2012 Aug;2(4):453-8. doi: 10.1016/j.coviro.2012.07.001. Epub 2012 Aug 1. Review.

18.

Epstein-Barr virus latent membrane protein-2A induces ITAM/Syk- and Akt-dependent epithelial migration through αv-integrin membrane translocation.

Fotheringham JA, Coalson NE, Raab-Traub N.

J Virol. 2012 Oct;86(19):10308-20. doi: 10.1128/JVI.00853-12. Epub 2012 Jul 25.

19.

Infection of Epstein-Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expression.

Marquitz AR, Mathur A, Shair KH, Raab-Traub N.

Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9593-8. doi: 10.1073/pnas.1202910109. Epub 2012 May 30.

20.

Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice.

Vrazo AC, Chauchard M, Raab-Traub N, Longnecker R.

PLoS Pathog. 2012;8(4):e1002662. doi: 10.1371/journal.ppat.1002662. Epub 2012 Apr 19.

21.

Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) and LMP2A function cooperatively to promote carcinoma development in a mouse carcinogenesis model.

Shair KH, Bendt KM, Edwards RH, Nielsen JN, Moore DT, Raab-Traub N.

J Virol. 2012 May;86(9):5352-65. doi: 10.1128/JVI.07035-11. Epub 2012 Feb 22.

22.

The role of miRNAs and EBV BARTs in NPC.

Marquitz AR, Raab-Traub N.

Semin Cancer Biol. 2012 Apr;22(2):166-72. doi: 10.1016/j.semcancer.2011.12.001. Epub 2011 Dec 10. Review.

23.

Microvesicles and viral infection.

Meckes DG Jr, Raab-Traub N.

J Virol. 2011 Dec;85(24):12844-54. doi: 10.1128/JVI.05853-11. Epub 2011 Oct 5. Review.

24.

EBV-induced oncogenesis.

Raab-Traub N.

In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 55.

25.

The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim.

Marquitz AR, Mathur A, Nam CS, Raab-Traub N.

Virology. 2011 Apr 10;412(2):392-400. doi: 10.1016/j.virol.2011.01.028. Epub 2011 Feb 18.

26.

Epstein-Barr virus LMP1 activates EGFR, STAT3, and ERK through effects on PKCdelta.

Kung CP, Meckes DG Jr, Raab-Traub N.

J Virol. 2011 May;85(9):4399-408. doi: 10.1128/JVI.01703-10. Epub 2011 Feb 9.

27.

Human tumor virus utilizes exosomes for intercellular communication.

Meckes DG Jr, Shair KH, Marquitz AR, Kung CP, Edwards RH, Raab-Traub N.

Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20370-5. doi: 10.1073/pnas.1014194107. Epub 2010 Nov 8.

28.

Epstein-Barr virus latent membrane protein-2A-induced DeltaNp63alpha expression is associated with impaired epithelial-cell differentiation.

Fotheringham JA, Mazzucca S, Raab-Traub N.

Oncogene. 2010 Jul 29;29(30):4287-96. doi: 10.1038/onc.2010.175. Epub 2010 May 24.

30.

Transcriptional downregulation of p27KIP1 through regulation of E2F function during LMP1-mediated transformation.

Everly DN Jr, Mainou BA, Raab-Traub N.

J Virol. 2009 Dec;83(24):12671-9. doi: 10.1128/JVI.01422-09. Epub 2009 Oct 14.

31.

Epstein-Barr virus latent membrane protein-1 effects on junctional plakoglobin and induction of a cadherin switch.

Shair KH, Schnegg CI, Raab-Traub N.

Cancer Res. 2009 Jul 15;69(14):5734-42. doi: 10.1158/0008-5472.CAN-09-0468. Epub 2009 Jul 7.

32.

EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration.

Shair KH, Schnegg CI, Raab-Traub N.

Cancer Res. 2008 Sep 1;68(17):6997-7005. doi: 10.1158/0008-5472.CAN-08-1178.

33.

Post-transplantation lymphoproliferative disease: Epstein-Barr virus DNA levels, HLA-A3, and survival.

Wheless SA, Gulley ML, Raab-Traub N, McNeillie P, Neuringer IP, Ford HJ, Aris RM.

Am J Respir Crit Care Med. 2008 Nov 15;178(10):1060-5. doi: 10.1164/rccm.200804-531OC. Epub 2008 Aug 28.

PMID:
18755927
34.

Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing.

Edwards RH, Marquitz AR, Raab-Traub N.

J Virol. 2008 Sep;82(18):9094-106. doi: 10.1128/JVI.00785-08. Epub 2008 Jul 9.

35.
36.

The ID proteins contribute to the growth of rodent fibroblasts during LMP1-mediated transformation.

Everly DN Jr, Mainou BA, Raab-Traub N.

Virology. 2008 Jul 5;376(2):258-69. doi: 10.1016/j.virol.2007.12.003. Epub 2008 May 5.

37.

Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3.

Kung CP, Raab-Traub N.

J Virol. 2008 Jun;82(11):5486-93. doi: 10.1128/JVI.00125-08. Epub 2008 Mar 26.

38.

EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas.

Shair KH, Bendt KM, Edwards RH, Bedford EC, Nielsen JN, Raab-Traub N.

PLoS Pathog. 2007 Nov;3(11):e166.

40.

Unique signaling properties of CTAR1 in LMP1-mediated transformation.

Mainou BA, Everly DN Jr, Raab-Traub N.

J Virol. 2007 Sep;81(18):9680-92. Epub 2007 Jul 11.

41.

Clonal evolution of lymphoblastoid cell lines.

Ryan JL, Kaufmann WK, Raab-Traub N, Oglesbee SE, Carey LA, Gulley ML.

Lab Invest. 2006 Nov;86(11):1193-200. Epub 2006 Oct 2.

42.

LMP1 strain variants: biological and molecular properties.

Mainou BA, Raab-Traub N.

J Virol. 2006 Jul;80(13):6458-68.

43.

Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed.

Cai X, Schäfer A, Lu S, Bilello JP, Desrosiers RC, Edwards R, Raab-Traub N, Cullen BR.

PLoS Pathog. 2006 Mar;2(3):e23. Epub 2006 Mar 24.

44.

Multiple Epstein-Barr virus strains in patients with infectious mononucleosis: comparison of ex vivo samples with in vitro isolates by use of heteroduplex tracking assays.

Tierney RJ, Edwards RH, Sitki-Green D, Croom-Carter D, Roy S, Yao QY, Raab-Traub N, Rickinson AB.

J Infect Dis. 2006 Jan 15;193(2):287-97. Epub 2005 Dec 14.

PMID:
16362894
45.

LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice.

Thornburg NJ, Kulwichit W, Edwards RH, Shair KH, Bendt KM, Raab-Traub N.

Oncogene. 2006 Jan 12;25(2):288-97.

PMID:
16247482
46.
47.

Ribonucleotide reductase inhibitors enhance cidofovir-induced apoptosis in EBV-positive nasopharyngeal carcinoma xenografts.

Wakisaka N, Yoshizaki T, Raab-Traub N, Pagano JS.

Int J Cancer. 2005 Sep 10;116(4):640-5.

50.

Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas.

Feng WH, Cohen JI, Fischer S, Li L, Sneller M, Goldbach-Mansky R, Raab-Traub N, Delecluse HJ, Kenney SC.

J Natl Cancer Inst. 2004 Nov 17;96(22):1691-702.

PMID:
15547182

Supplemental Content

Loading ...
Support Center